Phosphorylation of (Ser 291) in the linker insert of Syk negatively regulates ITAM signaling in platelets

References

• Geahlen RL. Syk and pTyr’d: signaling through the B cell antigen receptor. Biochim Biophys Acta. 2009;1793(7):1115–9. doi:10.1016/j.bbamcr.2009.03.004.
   PubMed Web of Science ®Google Scholar
• Mocsai A, Ruland J, Tybulewicz VL. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol. 2010;10(6):387–402. doi:10.1038/nri2765.
   PubMed Web of Science ®Google Scholar
• Bradshaw JM. The Src, Syk, and Tec family kinases: distinct types of molecular switches. Cell Signal. 2010;22(8):1175–84. doi:10.1016/j.cellsig.2010.03.001.
   PubMed Web of Science ®Google Scholar
• Tsang E, Giannetti AM, Shaw D, Dinh M, Tse JK, Gandhi S, Ho H, Wang S, Papp E, Bradshaw JM. Molecular mechanism of the Syk activation switch. J Biol Chem. 2008;283(47):32650–9. doi:10.1074/jbc.M806340200.
   PubMed Web of Science ®Google Scholar
• Rowley RB, Bolen JB, Fargnoli J. Molecular cloning of rodent p72Syk. Evidence of alternative mRNA splicing. J Biol Chem. 1995;270(21):12659–64. doi:10.1074/jbc.270.21.12659.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Kairiyama L, Araki M, Nagasawa S. Evidence for involvement of two isoforms of Syk protein-tyrosine kinase in signal transduction through the high affinity IgE receptor on rat basophilic leukemia cells. J Biochem (Tokyo). 1998;123(6):1199–207. doi:10.1093/oxfordjournals.jbchem.a022061.
   PubMed Web of Science ®Google Scholar
• Duta F, Ulanova M, Seidel D, Puttagunta L, Musat-Marcu S, Harrod KS, Schreiber AD, Steinhoff U, Befus AD. Differential expression of spleen tyrosine kinase Syk isoforms in tissues: effects of the microbial flora. Histochem Cell Biol. 2006;126(4):495–505. doi:10.1007/s00418-006-0188-z.
   PubMed Web of Science ®Google Scholar
• Wang L, Duke L, Zhang PS, Arlinghaus RB, Symmans WF, Sahin A, Mendez R, Dai JL. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res. 2003;63(15):4724–30.
   PubMed Web of Science ®Google Scholar
• Kumar Singh P, Dangelmaier CA, Reddy Vari H, Tsygankov AY, Kunapuli SP. Biochemical characterization of spleen tyrosine kinase (SYK) isoforms in platelets. Platelets. 2023;34(1):2249549. doi:10.1080/09537104.2023.2249549.
   PubMed Web of Science ®Google Scholar
• Yanagi S, Inatome R, Takano T, Yamamura H. Syk expression and novel function in a wide variety of tissues. Biochem Biophys Res Commun. 2001;288(3):495–8. doi:10.1006/bbrc.2001.5788.
   PubMed Web of Science ®Google Scholar
• Tsygankov AY. Non-receptor protein tyrosine kinases. Front Biosci. 2003;8(6):s595–635. doi:10.2741/1106.
   PubMedGoogle Scholar
• Coopman PJ, Mueller SC. The Syk tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett. 2006;241(2):159–73. doi:10.1016/j.canlet.2005.11.004.
   PubMed Web of Science ®Google Scholar
• Hong J, Yuan Y, Wang J, Liao Y, Zou R, Zhu C, Li B, Liang Y, Huang P, Wang Z, et al. Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma. Cancer Res. 2014;74(6):1845–56. doi:10.1158/0008-5472.CAN-13-2104.
   PubMed Web of Science ®Google Scholar
• Coebergh van den Braak RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, Bril SI, van Galen A, Smid M, Biermann K, van Krieken J, Kloosterman WP, et al. High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients. PLOS ONE. 2017;12(9):e0185607. doi:10.1371/journal.pone.0185607.
   PubMed Web of Science ®Google Scholar
• Prinos P, Garneau D, Lucier JF, Gendron D, Couture S, Boivin M, Brosseau JP, Lapointe E, Thibault P, Durand M, et al. Alternative splicing of SYK regulates mitosis and cell survival. Nature Structural & Molecular Biology. 2011;18(6):673–9. doi:10.1038/nsmb.2040.
   PubMed Web of Science ®Google Scholar
• Ni B, Hu J, Chen D, Li L, Chen D, Wang J, Wang L. Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression. Oncol Lett. 2016;12(3):1737–44. doi:10.3892/ol.2016.4858.
   PubMed Web of Science ®Google Scholar
• Denis V, Cassagnard N, Del Rio M, Cornillot E, Bec N, Larroque C, Jeanson L, Jarlier M, Combes E, Robert B, et al. Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells. PLOS ONE. 2022;17(9):e0274390. doi:10.1371/journal.pone.0274390.
   PubMed Web of Science ®Google Scholar
• Siraganian RP, de Castro RO, Barbu EA, Zhang J. Mast cell signaling: the role of protein tyrosine kinase Syk, its activation and screening methods for new pathway participants. FEBS Lett. 2010;584(24):4933–40. doi:10.1016/j.febslet.2010.08.006.
   PubMed Web of Science ®Google Scholar
• Sada K, Takano T, Yanagi S, Yamamura H. Structure and function of Syk protein-tyrosine kinase. J Biochem. 2001;130(2):177–86. doi:10.1093/oxfordjournals.jbchem.a002970.
   PubMed Web of Science ®Google Scholar
• Kulathu Y, Grothe G, Reth M. Autoinhibition and adapter function of Syk. Immunol Rev. 2009;232(1):286–99. doi:10.1111/j.1600-065X.2009.00837.x.
   PubMedGoogle Scholar
• Paris LL, Hu J, Galan J, Ong SS, Martin VA, Ma H, Tao WA, Harrison ML, Geahlen RL. Regulation of Syk by phosphorylation on serine in the linker insert. J Biol Chem. 2010;285(51):39844–54. doi:10.1074/jbc.M110.164509.
   PubMed Web of Science ®Google Scholar
• Bohnenberger H, Oellerich T, Engelke M, Hsiao HH, Urlaub H, Wienands J. Complex phosphorylation dynamics control the composition of the Syk interactome in B cells. Eur J Immunol. 2011;41(6):1550–62. doi:10.1002/eji.201041326.
   PubMed Web of Science ®Google Scholar
• Mohammad DK, Nore BF, Gustafsson MO, Mohamed AJ, Smith CIE. Protein kinase B (AKT) regulates SYK activity and shuttling through 14-3-3 and importin 7. Int J Biochem Cell Biol. 2016;78:63–74. doi:10.1016/j.biocel.2016.06.024.
   PubMed Web of Science ®Google Scholar
• Buitrago L, Bhavanasi D, Dangelmaier C, Manne BK, Badolia R, Borgognone A, Tsygankov AY, McKenzie SE, Kunapuli SP. Tyrosine phosphorylation on spleen tyrosine kinase (Syk) is differentially regulated in human and murine platelets by protein kinase C isoforms. Journal of Biological Chemistry. 2013;288(40):29160–9. doi:10.1074/jbc.M113.464107.
   PubMed Web of Science ®Google Scholar
• Makhoul S, Dorschel S, Gambaryan S, Walter U, Jurk K. Feedback regulation of Syk by protein Kinase C in human platelets. Int J Mol Sci. 2019;21(1):176. doi:10.3390/ijms21010176.
   PubMed Web of Science ®Google Scholar
• Kostyak JC, Mauri BR, Dangelmaier C, Patel A, Zhou Y, Eble JA, Tsygankov AY, McKenzie SE, Kunapuli SP. TULA-2 deficiency enhances platelet functional responses to CLEC-2 agonists. TH Open. 2018;2(4):411–9. doi:10.1055/s-0038-1676358.
   Google Scholar
• Patel A, Kostyak J, Dangelmaier C, Badolia R, Bhavanasi D, Aslan JE, Merali S, Kim S, Eble JA, Goldfinger L, et al. ELMO1 deficiency enhances platelet function. Blood Adv. 2019;3(4):575–87. doi:10.1182/bloodadvances.2018016444.
   PubMed Web of Science ®Google Scholar
• Daniel JL, Dangelmaier CA, Mada S, Buitrago L, Jin J, Langdon WY, Tsygankov AY, Kunapuli SP, Sanjay A. Cbl-b is a novel physiologic regulator of glycoprotein VI-dependent platelet activation. J Biol Chem. 2010;285(23):17282–91. doi:10.1074/jbc.M109.080200.
   PubMed Web of Science ®Google Scholar
• Dangelmaier CA, Patchin M, Vajipayajula DN, Vari HR, Singh PK, Wright MN, Kostyak JC, Tsygankov AY, Kunapuli SP. Phosphorylation of spleen tyrosine kinase at Y346 negatively regulates ITAM-mediated signaling and function in platelets. J Biol Chem. 2023;299(7):104865. doi:10.1016/j.jbc.2023.104865.
   PubMedGoogle Scholar
• Siraganian RP, Zhang J, Suzuki K, Sada K. Protein tyrosine kinase Syk in mast cell signaling. Mol Immunol. 2002;38(16–18):1229–33. doi:10.1016/S0161-5890(02)00068-8.
   PubMed Web of Science ®Google Scholar
• Sada K, Takano T, Yanagi S, Yamamura H. Structure and function of syk protein-tyrosine kinase. J Biochem (Tokyo). 2001;130(2):177–86. doi:10.1093/oxfordjournals.jbchem.a002970.
   PubMed Web of Science ®Google Scholar
• Turner M, Schweighoffer E, Colucci F, Di Santo JP, Tybulewicz VL. Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol Today. 2000;21(3):148–54. doi:10.1016/S0167-5699(99)01574-1.
   PubMedGoogle Scholar
• Swamy M. ZAP70 holds the key to kinetic proofreading for TCR ligand discrimination. Nat Immunol. 2022;23(9):1293–4. doi:10.1038/s41590-022-01297-w.
   PubMed Web of Science ®Google Scholar
• Garcia A, Shankar H, Murugappan S, Kim S, Kunapuli SP. Regulation and functional consequences of ADP receptor-mediated Erk2 activation in platelets. Biochem J. 2007;404(2):299–308. doi:10.1042/BJ20061584.
   PubMedGoogle Scholar
• Zhang P, Ungern-Sternberg S, Hastenplug L, Solari FA, Sickmann A, Kuijpers MJE, Heemskerk JWM, Walter U, Jurk K. Multi-phased kinetics and interaction of protein kinase signaling in glycoprotein VI-Induced platelet αIIbβ3 integrin activation and degranulation. Thromb Haemost. 2024; In press. 10.1055/a-2311-0117.
   Web of Science ®Google Scholar
• Kim S, Foster C, Lecchi A, Quinton TM, Prosser DM, Jin J, Cattaneo M, Kunapuli SP. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Blood. 2002;99(10):3629–36. doi:10.1182/blood.V99.10.3629.
   PubMed Web of Science ®Google Scholar
• Watson SP, Auger JM, McCarty OJ, Pearce AC. GPVI and integrin alphaIib beta3 signaling in platelets. J Thromb Haemost. 2005;3(8):1752–62. doi:10.1111/j.1538-7836.2005.01429.x.
   PubMed Web of Science ®Google Scholar